CSL NEW ZEALAND MONOFIX-VF dried Factor IX (Human) powder for injection

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

Factor IX, Quantity: 500 IU

Dostępny od:

CSL Behring Australia Pty Ltd

Forma farmaceutyczna:

Injection, diluent for

Skład:

Excipient Ingredients: water for injections

Droga podania:

Intravenous

Sztuk w opakowaniu:

500 IU

Typ recepty:

(S1) This Schedule is intentionally blank

Wskazania:

MonoFIX-VF is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia B. MonoFIX-VF is not indicated for the treatment of Factor II, VII or X deficiencies because it does not contain therapeutic levels of these coagulation factors. MonoFIX-VF is not indicated for the treatment of haemophilia A patients with Factor VIII inhibitors.

Podsumowanie produktu:

Visual Identification: Clear,colourless solution free from visible particles; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status autoryzacji:

Listed (Export Only)

Data autoryzacji:

1998-06-05